United Health (UNH) Offering Possible 25% Return Over the Next 10 Calendar Days

United Health's most recent trend suggests a bullish bias. One trading opportunity on United Health is a Bull Put Spread using a strike $285.00 short put and a strike $280.00 long put offers a potential 25% return on risk over the next 10 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $285.00 by expiration. The full premium credit of $1.00 would be kept by the premium seller. The risk of $4.00 would be incurred if the stock dropped below the $280.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for United Health is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for United Health is bullish.

The RSI indicator is at 42.73 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for United Health

Microsoft Is Best Stock in Dow Jones This Week: Buy or Sell?
Sun, 09 Feb 2020 03:45:00 +0000
Microsoft, IBM, and UnitedHealth were the best stocks in the Dow Jones this week after Uber earnings and cruise ships were hit by the coronavirus.

Generac Holdings Set to Join S&P MidCap 400; Alexander & Baldwin and America's Car-Mart to Join S&P SmallCap 600
Fri, 07 Feb 2020 22:54:00 +0000
S&P; Dow Jones Indices will make the following changes to the S&P; MidCap 400 and S&P; SmallCap 600 effective prior to the open of trading on Thursday, February 13:

Why Trump and UNH Stock Have Four More Years
Fri, 07 Feb 2020 12:10:08 +0000
I'm not going to pretend to know all the reasons why shares of UnitedHealth Group (NYSE:UNH) popped up more than 5% on the Feb. 5 session. But I have a strong suspicion that astute Wall Street powerbrokers watched the prior evening's State of the Union Address. The unprecedented drama that unfolded there bodes very well for our president and by logical deduction, UNH stock.Source: Ken Wolter / Shutterstock.com First, let me back up and provide some context. Last year saw UNH return 22% for stakeholders, which isn't a bad deal for a big, boring blue-chip investment. Arguably, most folks buy equity in UnitedHealth for stable revenue streams and a sure dividend. Never does this name appear on a list of get-rich-quick schemes.However, the net bullishness in UNH stock overlooks how choppy and volatile it was in 2019. By the end of the first half, shares were basically flat because, political momentum picked up for "Medicare for All" proposals. So much so that UnitedHealth Group CEO David Wichmann warned that such proposals would "destabilize the nation's health system."InvestorPlace – Stock Market News, Stock Advice & Trading TipsAccording to CNBC, Wichmann rarely discusses politics. Therefore, his opinion stood out more than usual. Not surprisingly, it also negatively affected UNH stock, with shares sinking from mid-July to late September. * 7 Utility Stocks to Buy That Offer Juicy Dividends The other significant contextual factor is President Trump and his trade war against China. As you know, UNH stock responded very positively to Trump's administration. Since inauguration day, shares have nearly doubled.However, a poor economy represented a serious risk to a second term and that translates to potentially large-scale changes in the healthcare system that Wichmann fears.Thankfully, House speaker Nancy Pelosi assuaged those fears. Pelosi Stunt Will Fire-up UNH StockLike probably most Americans, I watched the SOTU address because I knew I was going to watch a train wreck. I wasn't disappointed.The fireworks started right off the bat, with Trump seemingly declining Pelosi's offer of a handshake. Presumably, in response, Pelosi cut short the customary introduction of the President.I can overlook the chilly interaction between the two based on the impeachment controversy. What I could not overlook – and millions of American voters would surely agree with me – were Pelosi's childish antics in the background. Finally, after Trump concluded his speech, she ripped her copy of it in plain view of the camera.From her point of view, she protested what she claimed were "page after page" of "mistruths." She's passionate, I'll give her that. But in her childish antics, she might as well have given what the Republicans chanted earlier that evening: "Four more years!"In the military and the various uniformed services of the federal government, we have a tradition of saluting (senior) officers. You might not personally like the officer. Ultimately, though, he or she represents the office they are holding and that is what uniformed members salute.By ripping the speech, Pelosi dishonored the highest traditions of this country. She further disrespected the office of the Presidency of the United States. Honestly, it was one of the most shocking moments I have ever witnessed.Now, I recognize that the nation is deeply divided politically. But our government representatives must demonstrate basic decorum and etiquette when conducting official functions of the U.S. Failure to do so is an unconscionable insult, yet here we are.However, if you're long UNH stock, you're looking forward to celebrating November 2020. UnitedHealth Shareholders Breathing a Sigh of ReliefIf I wasn't clear above, let me state it bluntly: I wholeheartedly believe that Donald J. Trump will win his second term. I'll go a step further. I think it'll be a landslide victory.Americans are not the smartest creatures on this planet. But I thank my lucky stars that America's forefathers apparently forecasted our intellectual and moral decline, and the gift they gave us, the Electoral College, will prevent the tyranny of stupidity (see progressive California's business-killing AB 5 as an example) and emotional instability for at least the next few years.However, it was rough going for some time for "The Donald," which is why UNH stock was turbulent in 2019. But with a phase one trade deal signed, and headline economic numbers moving in the right direction at the right time, it'd be crazy to bet on anyone else.It's nothing personal…it's just business.As of this writing, Josh Enomoto did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Utility Stocks to Buy That Offer Juicy Dividends * 10 Gold and Silver Stocks to Profit Off 2020's Fear Trade * 3 Top Companies That Should Be More Careful With Your Data The post Why Trump and UNH Stock Have Four More Years appeared first on InvestorPlace.

Cigna (CI) Q4 Earnings and Revenues Beat Estimates, Rise Y/Y
Thu, 06 Feb 2020 15:36:03 +0000
Cigna (CI) Q4 results reflect revenue and membership growth on the back of Express Scripts acquisition.

US Indexes Close Higher With Impeachment Acquittal
Thu, 06 Feb 2020 14:49:00 +0000
S&P; 500 up 1.13% Continue reading…

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.